MediWound, Vericel tumble as FDA declines to approve burns treatment

Vericel

29/06/2021 15:16

** Shares of drugmaker  MDWD.O  and stem cell therapy
developer  VCEL.O  plunge between 15% and 32% 
    ** FDA declines to accept MDWD's lead burn treatment,
NexoBrid  urn:newsml:reuters.com:*:nL3N2OB2ZW
    ** Agency has pointed to issues related to the chemistry,
manufacturing and controls (CMC) section of the application and
has requested additional information
    ** Inspection at co's manufacturing facilities in Taiwan and
Israel required before approving the treatments
    ** MDWD up 5% YTD, while VCEL jumped 87.2%

 (Reporting by Trisha Roy in Bengaluru)
 ((Trisha.Roy@thomsonreuters.com))